BioSpace News Archive

Chiesi USA, a specialty pharmaceutical company based in Cary, N.C., is proud to once again support March of Dimes in its mission to improve the health and lives of moms and babies during November’s Prematurity Awareness Month observance.

MedLite ID is very pleased to announce healthcare sales veteran, Bruce Thompson, joins the firm as Vice President of Sales.

Healthmap Solutions, Inc., an industry-leading Kidney Health Management company, announced it has earned Population Health Program Accreditation from the National Committee for Quality Assurance.

Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced that members of the Morphic management are scheduled to participate in the Jefferies Virtual London Healthcare Conference with a Company presentation at 2:55 PM ET on Wednesday, November 18, 2020. A live webcast of the company presentation will be avai

AllMed Healthcare Management, Inc., a leading provider of utilization management (UM) and independent review (IRO) services, today announced that Jeff Keating has joined its executive leadership team as Chief Technology Officer (CTO).

Today, ELITechGroup MDx LLC, a leading global provider of molecular diagnostic testing products, announced it submitted the SARS-CoV-2 Plus ELITe MGB® Assay to the U.S. Food & Drug Association’s (FDA’s) for Emergency Use Authorization (EUA), following the Molecular Diagnostic Template for Commercial Manufacturers.

Sysmex America, Inc., a leading diagnostic company offering hematology, urinalysis, informatics systems and flow cytometry testing solutions for optimal clinical laboratory performance, today announced it will add the CellaVision® DC-1 to its portfolio of CellaVision products for low-volume hematology lab

AccuReg, a healthcare technology solutions company offering a full suite of front-end revenue cycle management solutions for health systems and hospitals, has acquired Orlando-based Zenig, an innovator in patient engagement technology solutions that enable touchless check-in, virtual waiting rooms, patient flow and bi-directional communication methods.

Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China , announced that, after consulting with the U.S. Food and Drug Administration (FDA), the Company has initiated a Phase Ib/IIa clinical study of KPG-818 in patients with Systemic Lupus Erythematosus (SLE).

Children’s Hospital Colorado announced a strategic partnership that will utilize 2nd.MD’s technology and extensive employer and health plan network to provide millions of people across the United States direct, virtual access to Children’s Colorado specialists.